42 U.S.C. § 244c — Cardiomyopathy research
submitted 82 years ago by Pub. L. 118-176 to r/title-42-THE-PUBLIC-HEALTH-AND-WELFARE · 224 words · no verdicts yet
The Secretary may work with the NIH to expand cardiomyopathy research, covering its causes, long-term outcomes, and effective treatments. This research must not needlessly repeat other agencies' work. Within 18 months, the Secretary must also report to Congress on NIH's cardiomyopathy research plans.
(a) In general. The Secretary*, working with the Director* of the National Institutes of Health, may expand and coordinate NIH's research on cardiomyopathy. This research may look at what causes cardiomyopathy, including genetic causes and molecular markers; the long-term health outcomes for people with cardiomyopathy, from infants to elderly people; and studies that use long-term data and past records to find effective treatments and outcomes.
(b) Nonduplication. The Secretary must make sure this research doesn't needlessly repeat work already being done by other agencies or offices within the Department of Health and Human Services.
(c) NIH report. Within 18 months after December 23, 2024, the Secretary — working with the NIH Director — must send Congress a report. The report must describe NIH's ongoing cardiomyopathy research, lay out a research agenda for adult forms of the disease, describe plans for researching cardiomyopathy in children, and identify where more research is needed most.
(d) Cardiomyopathy defined. In this section, "cardiomyopathy" has the same meaning as in section 244a.
The Secretary*, in consultation with the Director* of the National Institutes of Health, may expand and coordinate research and related activities of the National Institutes of Health with respect to cardiomyopathy, which may include research with respect to—
causation of cardiomyopathy, including genetic causes and molecular biomarkers;
long-term health outcomes in individuals with cardiomyopathy, including infants, children, teenagers, adults, and elderly individuals; and
studies using longitudinal data and retrospective analysis to identify effective treatments and outcomes for individuals with cardiomyopathy.
The Secretary shall ensure that any research and activities related to cardiomyopathy under this section do not unnecessarily duplicate activities, programs, or efforts of other agencies and offices within the Department of Health and Human Services.
Not later than 18 months after December 23, 2024, the Secretary, in consultation with the Director of the National Institutes of Health, shall submit to Congress a report—
outlining the ongoing research efforts of the National Institutes of Health regarding cardiomyopathy; and
identifying—
a research agenda regarding adult forms of cardiomyopathy;
plans for researching cardiomyopathy affecting the pediatric population; and
the areas of greatest need for such research.
In this section, the term “cardiomyopathy” has the meaning given to such term in section 244a of this title.
Source credit: (July 1, 1944, ch. 373, title III, § 312C, as added Pub. L. 118–176, § 2(a), Dec. 23, 2024, 138 Stat. 2608.)
- 1944Enacted · Pub. L. 118-176 · 138 Stat. 2608
A history note hasn’t been published yet. The record shows enactment by Pub. L. 118-176 on 1944-07-01.
all 0 arguments · sorted by: best
no arguments yet — make the first case